Correspondence 0001493152-24-021632 from Sanara MedTech Inc. (SMTI) (CIK 0000714256) (SMTI)
Sanara MedTech Inc. (SMTI) (CIK 0000714256)
Date: May 28, 2024 · CIK: 0000714256 · Accession: 0001493152-24-021632
AI Filing Summary & Sentiment
File numbers found in text: 333-279592
Letter
Sanara MedTech Inc.
Summit Ave, Suite 414
Fort Worth, Texas 76102
May 28, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
Washington, D.C. 20549
Attention: Abby Adams
Re:
Sanara MedTech Inc.
Registration Statement on Form S-3
Filed on May 21, 2024
File No. 333-279592 (the “Registration Statement”)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, Sanara MedTech Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective at 9:00 a.m., Eastern Time, on May 31, 2024, or as soon thereafter as practicable.
Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Matthew L. Fry, Esq. at (214) 651-5443.
Very
truly yours,
SANARA
MEDTECH INC.
Show Raw Text
CORRESP
1
filename1.htm
Sanara
MedTech Inc.
1200
Summit Ave, Suite 414
Fort
Worth, Texas 76102
May
28, 2024
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
Office
of Industrial Applications and Services
Washington,
D.C. 20549
Attention:
Abby Adams
Re:
Sanara
MedTech Inc.
Registration
Statement on Form S-3
Filed
on May 21, 2024
File
No. 333-279592 (the “Registration Statement”)
Request
for Acceleration
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under
the Securities Act of 1933, as amended, Sanara MedTech Inc. (the “Company”) hereby respectfully requests acceleration
of the effective date of the Registration Statement so that it may become effective at 9:00 a.m., Eastern Time, on May 31, 2024, or as
soon thereafter as practicable.
Should
any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes
and Boone, LLP, attention: Matthew L. Fry, Esq. at (214) 651-5443.
Very
truly yours,
SANARA
MEDTECH INC.
By:
/s/
Michael D. McNeil
Michael
D. McNeil
Chief
Financial Officer
cc:
Matthew
L. Fry, Esq., Haynes and Boone, LLP